📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment (2019)

First Author: Rushworth L

Attributed to: Warwick Integrative Synthetic Biology Centre funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-019-0681-5

PubMed Identifier: 31844184

Publication URI: http://europepmc.org/abstract/MED/31844184

Type: Journal Article/Review

Parent Publication: British Journal of Cancer

Issue: 4

ISSN: 0007-0920